Swiss National Bank’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.89M Sell
222,900
-12,900
-5% -$109K ﹤0.01% 1833
2025
Q1
$1.9M Sell
235,800
-3,200
-1% -$25.7K ﹤0.01% 1795
2024
Q4
$2.15M Sell
239,000
-26,200
-10% -$235K ﹤0.01% 1814
2024
Q3
$1.94M Sell
265,200
-3,300
-1% -$24.2K ﹤0.01% 1881
2024
Q2
$1.53M Hold
268,500
﹤0.01% 1947
2024
Q1
$1.35M Hold
268,500
﹤0.01% 2068
2023
Q4
$2.41M Sell
268,500
-30,200
-10% -$271K ﹤0.01% 1725
2023
Q3
$2.32M Buy
298,700
+19,400
+7% +$151K ﹤0.01% 1742
2023
Q2
$2.7M Buy
279,300
+18,600
+7% +$180K ﹤0.01% 1692
2023
Q1
$2.86M Sell
260,700
-30,500
-10% -$334K ﹤0.01% 1615
2022
Q4
$1.26M Buy
291,200
+5,500
+2% +$23.8K ﹤0.01% 2214
2022
Q3
$2.15M Buy
285,700
+25,100
+10% +$189K ﹤0.01% 1824
2022
Q2
$2.62M Hold
260,600
﹤0.01% 1729
2022
Q1
$3.23M Buy
260,600
+20,400
+8% +$253K ﹤0.01% 1739
2021
Q4
$5.49M Buy
240,200
+13,700
+6% +$313K ﹤0.01% 1408
2021
Q3
$5.01M Buy
226,500
+1,000
+0.4% +$22.1K ﹤0.01% 1461
2021
Q2
$2.93M Sell
225,500
-20,400
-8% -$265K ﹤0.01% 1848
2021
Q1
$3.2M Buy
245,900
+1,900
+0.8% +$24.7K ﹤0.01% 1721
2020
Q4
$3.37M Hold
244,000
﹤0.01% 1609
2020
Q3
$3.58M Buy
244,000
+63,400
+35% +$929K ﹤0.01% 1390
2020
Q2
$2.91M Buy
180,600
+23,200
+15% +$374K ﹤0.01% 1492
2020
Q1
$2.24M Buy
157,400
+4,900
+3% +$69.9K ﹤0.01% 1378
2019
Q4
$3.08M Buy
152,500
+30,500
+25% +$617K ﹤0.01% 1472
2019
Q3
$651K Buy
122,000
+10,200
+9% +$54.4K ﹤0.01% 2266
2019
Q2
$738K Buy
111,800
+13,700
+14% +$90.4K ﹤0.01% 2283
2019
Q1
$637K Hold
98,100
﹤0.01% 2291
2018
Q4
$667K Buy
98,100
+5,700
+6% +$38.8K ﹤0.01% 2229
2018
Q3
$608K Hold
92,400
﹤0.01% 2362
2018
Q2
$530K Hold
92,400
﹤0.01% 2428
2018
Q1
$486K Hold
92,400
﹤0.01% 2381
2017
Q4
$421K Buy
+92,400
New +$421K ﹤0.01% 2443